
Dx Deals: New Premerger Regulations Could Slow Down Pace of Transactions
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation

The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation

$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays

The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow

The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada

Most of Invitae's employees will be hired by Labcorp, which expects the deal to add about $275 million in annual revenue